TWST

Twist Bioscience Corp

May 18 • 04:00PM ET

49.79

+0.62 1.26 %

Healthcare • Diagnostics & Research • USA • Mid • NASD

| Held by: ARKK VTI XBI ARKG VB IWM VBK VXF IWO IBB

Index	RUT	P/E	-	EPS (ttm)	-1.33	Insider Own	4.34%	Shs Outstand	62.15M	Perf Week	-11.42%
Market Cap	3.10B	Forward P/E	-	EPS next Y	-1.37	Insider Trans	-9.53%	Shs Float	59.57M	Perf Month	-16.75%
Enterprise Value	3.02B	PEG	-	EPS next Q	-0.49	Inst Own	120.83%	Short Float	23.36%	Perf Quarter	-5.84%
Income	-81.28M	P/S	7.57	EPS this Y	-58.01%	Inst Trans	-4.73%	Short Ratio	10.85	Perf Half Y	66.52%
Sales	409.48M	P/B	6.80	EPS next Y	33.17%	ROA	-12.78%	Short Interest	13.91M	Perf YTD	56.97%
Book/sh	7.32	P/C	18.06	EPS next 5Y	10.30%	ROE	-18.16%	52W High	66.06 -24.63%	Perf Year	60.98%
Cash/sh	2.76	P/FCF	-	EPS past 3/5Y	31.51% 18.31%	ROIC	-15.04%	52W Low	23.30 113.69%	Perf 3Y	279.79%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	22.76% 33.11%	Gross Margin	52.07%	Volatility	7.23% 6.09%	Perf 5Y	-47.63%
Dividend TTM	-	EV/Sales	7.39	EPS Y/Y TTM	59.40%	Oper. Margin	-32.14%	ATR (14)	3.52	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.42	Sales Y/Y TTM	17.77%	Profit Margin	-19.85%	RSI (14)	38.91	Recom	1.22
Dividend Gr. 3/5Y	- -	Current Ratio	2.70	EPS Q/Q	-8.21%	SMA20	-13.23%	Beta	2.19	Target Price	66.75
Payout	-	Debt/Eq	0.21	Sales Q/Q	19.31%	SMA50	-4.73%	Rel Volume	0.89	Prev Close	49.17
Employees	979	LT Debt/Eq	0.19	Earnings	May 04 BMO	SMA200	29.15%	Avg Volume	1.28M	Price	49.79
IPO	Oct 31, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-48.72% 2.85%	Trades		Volume	1,144,046	Change	1.26%

Date	Action	Analyst	Rating Change	Price Target Change
May-05-26	Upgrade	Leerink Partners	Market Perform → Outperform	$70
Nov-04-25	Initiated	Stephens	Overweight	$41
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Jun-04-24	Initiated	Guggenheim	Buy	$53
Jan-17-24	Upgrade	Goldman	Neutral → Buy	$25 → $45
Sep-27-23	Initiated	Berenberg	Buy	$27
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$33
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform	$28 → $36
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral	$110
Apr-12-21	Initiated	Piper Sandler	Overweight	$150
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight	$100
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform	$90
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral	$27

Show Previous Ratings

May-05-26 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
May-04-26 12:45PM	Twist Bioscience Corporation Q2 2026 Earnings Call Summary (Moby) -6.97%
07:23AM	Twist Bioscience: Fiscal Q2 Earnings Snapshot (Associated Press)
07:20AM	Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences (Business Wire)
07:15AM	Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results (Business Wire)
08:00AM	Loading…
Apr-21-26 08:00AM	Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026 (Business Wire)
Feb-24-26 03:52PM	ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025 (Benzinga)
Feb-18-26 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
Feb-17-26 07:00AM	Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement (Business Wire) +7.68%
Feb-10-26 08:00AM	Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes (Business Wire)
Feb-09-26 12:06PM	Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor Ratification (MarketBeat)
Feb-03-26 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Feb-02-26 10:02PM	Twist Bioscience Corporation (TWST): A Bull Case Theory (Insider Monkey) +13.98%
02:27PM	Why Is Twist Bioscience Stock Soaring Monday? (Benzinga)
02:00PM	Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
12:52PM	Loading…
12:52PM	Twist Bioscience Q1 Earnings Call Highlights (MarketBeat)
08:25AM	Twist Bioscience (TWST) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:21AM	Twist Bioscience: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results (Business Wire)
Jan-27-26 10:00AM	Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jan-26-26 10:00AM	Will Twist Bioscience (TWST) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jan-12-26 08:00AM	Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue (Business Wire) +7.70%
Dec-31-25 06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:48PM	Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) (Insider Monkey)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-22-25 10:20PM	New Product Launch Strengthens Bull Case for Twist?Bioscience (?TWST) (Insider Monkey) +7.84%
Dec-18-25 08:00AM	Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference (Business Wire)
Dec-12-25 01:15PM	Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Dec-04-25 08:00AM	Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research (Business Wire) +5.26%
Nov-18-25 09:40AM	Company News for Nov 18, 2025 (Zacks)
04:45AM	Loading…
04:45AM	Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT (Insider Monkey)
Nov-17-25 10:13AM	Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? (Insider Monkey)
Nov-14-25 02:01PM	Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -10.13%
08:25AM	Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:34AM	Twist Bioscience: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results (Business Wire)
Nov-13-25 09:15AM	MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -6.18%
Nov-12-25 08:10AM	Ovid Therapeutics (OVID) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-06-25 05:20PM	Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-04-25 09:11AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More (24/7 Wall St.)
08:00AM	Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference (Business Wire)
Nov-03-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Oct-24-25 06:20AM	Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire) +7.16%
Oct-23-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025 (Business Wire)
Oct-22-25 08:53AM	Multiple Headwinds Hit Twist BioScience Corp. (TWST) in Q3 (Insider Monkey) -6.98%
Oct-06-25 08:00AM	Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle Sequencing Workflow for the AVITI System (Business Wire)
Oct-02-25 02:00PM	Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design (Business Wire)
Sep-24-25 04:47AM	Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience (Zacks)
Sep-23-25 09:23AM	5 Biotech Stocks Worth Adding to Your Portfolio Now (Zacks)
Sep-18-25 11:35AM	3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 (Zacks)
Sep-17-25 02:18PM	TD Cowen Reaffirms Buy on Twist Bioscience (TWST) Amid Scaling and Margin Gains (Insider Monkey)
Sep-03-25 08:00AM	Twist Bioscience to Present at Baird 2025 Global Healthcare Conference (Business Wire)
Sep-02-25 08:00AM	Twist Bioscience Collaborates with Synthetic Design Lab (Business Wire)
Aug-19-25 08:00AM	Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution (Business Wire)
Aug-13-25 07:30AM	[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
Aug-07-25 09:35AM	After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST) (Zacks)
Aug-06-25 08:00AM	Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors (Business Wire) -5.89%
Aug-05-25 03:08AM	Twist Bioscience Corp (TWST) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -8.90%
Aug-04-25 08:25AM	Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -10.30%
07:24AM	Twist Bioscience: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results (Business Wire)
Jul-31-25 08:00AM	Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model (Business Wire)
Jul-28-25 08:24AM	Is Twist Bioscience Corp. (TWST) Nearing Profitability? (Insider Monkey)
Jul-24-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Jul-14-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025 (Business Wire)
Jul-07-25 08:00AM	Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format (Business Wire) -6.76%
Jun-23-25 01:40AM	Twist and Element Biosciences Expands Pact for Sequencing Workflow Solutions (Insider Monkey)
May-22-25 08:00AM	Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions (Business Wire)
May-15-25 08:00AM	Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference (Business Wire)
May-13-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
May-08-25 11:43PM	Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) -5.49%
08:00AM	Twist Bioscience and Ginkgo Bioworks Revise Collaboration (Business Wire)
May-06-25 03:02AM	Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -8.85%
01:18AM	Q2 2025 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
May-05-25 11:41AM	Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript (Seeking Alpha) -8.44%
08:25AM	Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:25AM	Twist Bioscience: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results (Business Wire)
07:10AM	Twist Bioscience Spins Out DNA Data Storage as Independent Company (Business Wire)
May-02-25 09:23AM	What To Expect From Twist Bioscience Corp (TWST) Q2 2025 Earnings (GuruFocus.com)
May-01-25 02:06PM	Twist Bioscience: Experiencing Solid Growth But Significantly Overvalued (Seeking Alpha)
12:05PM	Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers (Seeking Alpha)
Apr-24-25 08:00AM	Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System (Business Wire) +6.78%
Apr-14-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025 (Business Wire)
Mar-31-25 09:03AM	The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics (Zacks)
08:00AM	Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics (Business Wire)
Mar-28-25 09:39AM	Promising Genomics & Synthetic Biology Stocks to Consider in 2025 (Zacks)
Mar-20-25 04:58PM	Twist Bioscience (TWST): The Worst High-Risk High-Reward Growth Stock to Buy (InsiderMonkey)
Mar-12-25 12:12PM	Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last? (Zacks)
Mar-11-25 07:30AM	Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost (Business Wire) +6.59%
Mar-01-25 02:38PM	Is Twist Bioscience Corporation (TWST) The Best Immunology Stock To Buy Now? (Insider Monkey)
Feb-25-25 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
Feb-19-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Feb-06-25 04:58PM	Twist Bioscience Corporation (TWST): Among Cathie Woods Top Stock Picks for 2025 (Insider Monkey)
12:00PM	Twist Bioscience (TWST) Upgraded to Buy: Here's What You Should Know (Zacks)
Feb-04-25 02:01AM	Twist Bioscience Corp (TWST) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
12:47AM	Q1 2025 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-03-25 08:25AM	Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:25AM	Twist Bioscience: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results (Business Wire)

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Co-FounderDr. Emily Marine Leproust Ph.D.

President & COODr. Patrick John Finn Ph.D.

Chief Financial OfficerMr. Adam Laponis

Chief Legal Officer & Corporate SecretaryMr. Dennis Cho J.D.

Senior Vice President of Human ResourcesMs. Paula Green

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JOHANNESSEN JAN	Director	May 12 '26	Option Exercise	14.00	12,000	168,000	29,754	May 14 04:05 PM
JOHANNESSEN JAN	Director	May 12 '26	Sale	56.12	12,000	673,440	17,754	May 14 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	May 08 '26	Sale	56.88	4,961	282,187	49,674	May 12 04:05 PM
JOHANNESSEN JAN	Director	May 12 '26	Proposed Sale	56.12	12,000	673,440		May 12 09:48 AM
WERNER ROBERT F.	Officer	May 08 '26	Proposed Sale	56.88	4,961	282,187		May 08 12:25 PM
Cho Dennis	See Remarks	May 04 '26	Sale	57.15	1,962	112,126	135,941	May 06 04:05 PM
Leproust Emily M.	Chief Executive Officer	May 04 '26	Sale	57.15	5,127	293,002	853,760	May 06 04:05 PM
Finn Patrick John	President and COO	May 04 '26	Sale	57.15	2,844	162,531	278,964	May 06 04:05 PM
Green Paula	SVP of Human Resources	May 04 '26	Sale	57.15	1,116	63,778	122,988	May 06 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	May 04 '26	Sale	57.15	164	9,372	54,635	May 06 04:05 PM
Leproust Emily M.	Officer	May 04 '26	Proposed Sale	57.15	5,127	293,002		May 04 03:20 PM
Green Paula	Officer	May 04 '26	Proposed Sale	57.15	1,116	63,778		May 04 03:19 PM
Finn Patrick John	Officer	May 04 '26	Proposed Sale	57.15	2,844	162,531		May 04 03:14 PM
WERNER ROBERT F.	Officer	May 04 '26	Proposed Sale	57.15	164	9,372		May 04 03:11 PM
Cho Dennis	Officer	May 04 '26	Proposed Sale	57.15	1,962	112,126		May 04 03:07 PM
Starovasnik Melissa A.	Director	Apr 27 '26	Sale	61.83	500	30,915	25,222	Apr 29 04:05 PM
Finn Patrick John	President and COO	Apr 23 '26	Sale	60.76	2,321	141,026	281,808	Apr 27 04:05 PM
Starovasnik Melissa A.	Director	Apr 27 '26	Proposed Sale	61.83	500	30,915		Apr 27 09:36 AM
Leproust Emily M.	Chief Executive Officer	Apr 22 '26	Option Exercise	8.82	8,061	71,098	866,948	Apr 23 04:05 PM
Leproust Emily M.	Chief Executive Officer	Apr 21 '26	Option Exercise	8.82	1,610	14,200	860,497	Apr 23 04:05 PM
Leproust Emily M.	Chief Executive Officer	Apr 22 '26	Sale	65.29	8,061	526,291	858,887	Apr 23 04:05 PM
Leproust Emily M.	Chief Executive Officer	Apr 21 '26	Sale	65.01	1,610	104,666	858,887	Apr 23 04:05 PM
Finn Patrick John	Officer	Apr 23 '26	Proposed Sale	60.76	2,321	141,027		Apr 23 03:19 PM
Leproust Emily M.	Officer	Apr 22 '26	Proposed Sale	65.29	8,061	526,290		Apr 22 03:52 PM
Leproust Emily M.	Officer	Apr 21 '26	Proposed Sale	65.01	1,610	104,665		Apr 21 04:13 PM
Laponis Adam	Chief Financial Officer	Apr 17 '26	Sale	60.00	4,000	240,000	118,694	Apr 21 04:05 PM
Laponis Adam	Officer	Apr 17 '26	Proposed Sale	60.00	4,000	240,000		Apr 17 01:07 PM
Laponis Adam	Chief Financial Officer	Apr 14 '26	Sale	55.00	3,000	165,000	122,694	Apr 16 04:05 PM
Laponis Adam	Officer	Apr 14 '26	Proposed Sale	55.00	3,000	165,000		Apr 14 03:20 PM
Laponis Adam	Chief Financial Officer	Apr 09 '26	Sale	49.89	2,597	129,562	125,694	Apr 13 04:05 PM
Laponis Adam	Officer	Apr 09 '26	Proposed Sale	49.89	2,597	129,561		Apr 09 03:21 PM
Starovasnik Melissa A.	Director	Apr 01 '26	Sale	51.00	1,000	51,000	25,722	Apr 03 04:00 PM
Starovasnik Melissa A.	Director	Apr 01 '26	Proposed Sale	51.00	1,000	51,000		Apr 01 01:12 PM
Cho Dennis	See Remarks	Mar 20 '26	Sale	43.79	354	15,500	137,903	Mar 24 04:05 PM
Green Paula	SVP of Human Resources	Mar 20 '26	Sale	43.79	297	13,005	124,104	Mar 24 04:05 PM
Leproust Emily M.	Chief Executive Officer	Mar 20 '26	Sale	43.79	1,742	76,276	858,887	Mar 24 04:05 PM
Leproust Emily M.	Officer	Mar 20 '26	Proposed Sale	43.79	1,742	76,276		Mar 20 03:40 PM
Cho Dennis	Officer	Mar 20 '26	Proposed Sale	43.79	354	15,500		Mar 20 03:38 PM
Green Paula	Officer	Mar 20 '26	Proposed Sale	43.79	297	13,005		Mar 20 03:37 PM
CHESS ROBERT	Director	Mar 17 '26	Option Exercise	11.89	10,000	118,900	31,084	Mar 19 04:05 PM
CHESS ROBERT	Director	Mar 17 '26	Sale	47.00	10,000	470,000	21,084	Mar 19 04:05 PM
CHESS ROBERT	Director	Mar 17 '26	Proposed Sale	47.00	10,000	470,000		Mar 17 02:17 PM
WERNER ROBERT F.	Chief Accounting Officer	Mar 06 '26	Sale	46.43	246	11,421	54,799	Mar 10 04:06 PM
Cho Dennis	See Remarks	Mar 06 '26	Sale	46.43	425	19,731	138,257	Mar 10 04:05 PM
Green Paula	SVP of Human Resources	Mar 06 '26	Sale	46.43	935	43,408	124,401	Mar 10 04:05 PM
Leproust Emily M.	Chief Executive Officer	Mar 06 '26	Sale	46.43	2,423	112,490	860,629	Mar 10 04:05 PM
WERNER ROBERT F.	Officer	Mar 06 '26	Proposed Sale	46.43	246	11,421		Mar 06 03:42 PM
Green Paula	Officer	Mar 06 '26	Proposed Sale	46.43	935	43,408		Mar 06 03:19 PM
Cho Dennis	Officer	Mar 06 '26	Proposed Sale	46.43	425	19,731		Mar 06 03:13 PM
Leproust Emily M.	Officer	Mar 06 '26	Proposed Sale	46.43	2,423	112,491		Mar 06 03:10 PM
Finn Patrick John	President and COO	Feb 23 '26	Sale	46.71	4,294	200,572	284,129	Feb 25 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Feb 23 '26	Sale	46.71	1,693	79,080	55,045	Feb 25 04:05 PM
Laponis Adam	Chief Financial Officer	Feb 23 '26	Sale	46.71	2,085	97,390	128,291	Feb 25 04:05 PM
Leproust Emily M.	Chief Executive Officer	Feb 23 '26	Sale	46.71	7,205	336,544	863,052	Feb 25 04:05 PM
Green Paula	SVP of Human Resources	Feb 23 '26	Sale	46.71	1,465	68,430	125,336	Feb 25 04:05 PM
Cho Dennis	See Remarks	Feb 23 '26	Sale	46.71	844	39,423	138,682	Feb 25 04:05 PM
Leproust Emily M.	Officer	Feb 23 '26	Proposed Sale	46.71	7,205	336,544		Feb 23 03:34 PM
Cho Dennis	Officer	Feb 23 '26	Proposed Sale	46.71	844	39,423		Feb 23 03:20 PM
Laponis Adam	Officer	Feb 23 '26	Proposed Sale	46.71	2,085	97,390		Feb 23 03:18 PM
Green Paula	Officer	Feb 23 '26	Proposed Sale	46.71	1,465	68,430		Feb 23 03:18 PM
Finn Patrick John	Officer	Feb 23 '26	Proposed Sale	46.71	4,294	200,572		Feb 23 03:18 PM
WERNER ROBERT F.	Officer	Feb 23 '26	Proposed Sale	46.71	1,693	79,080		Feb 23 03:17 PM
Green Paula	SVP of Human Resources	Feb 17 '26	Sale	52.40	39,404	2,064,770	126,041	Feb 19 04:05 PM
Finn Patrick John	President and COO	Feb 17 '26	Option Exercise	25.46	50,505	1,285,841	356,755	Feb 19 04:05 PM
Finn Patrick John	President and COO	Feb 17 '26	Sale	51.65	68,967	3,562,417	287,788	Feb 19 04:05 PM
CHESS ROBERT	Director	Feb 13 '26	Sale	48.26	2,184	105,402	21,084	Feb 18 04:05 PM
Green Paula	Officer	Feb 17 '26	Proposed Sale	52.40	16,739	877,124		Feb 17 05:27 PM
Green Paula	Officer	Feb 17 '26	Proposed Sale	52.40	22,665	1,187,646		Feb 17 05:09 PM
Finn Patrick John	Officer	Feb 17 '26	Proposed Sale	51.65	68,967	3,562,415		Feb 17 04:42 PM
Finn Patrick John	President and COO	Feb 12 '26	Option Exercise	25.33	2,500	63,320	310,288	Feb 17 04:25 PM
Finn Patrick John	President and COO	Feb 13 '26	Option Exercise	25.29	1,212	30,647	308,000	Feb 17 04:25 PM
Finn Patrick John	President and COO	Feb 12 '26	Sale	50.23	3,500	175,788	306,788	Feb 17 04:25 PM
Finn Patrick John	President and COO	Feb 13 '26	Sale	50.04	1,750	87,572	306,250	Feb 17 04:25 PM
Laponis Adam	Chief Financial Officer	Feb 12 '26	Sale	50.00	7,000	350,000	130,031	Feb 13 05:10 PM
Finn Patrick John	Officer	Feb 13 '26	Proposed Sale	50.04	1,750	87,572		Feb 13 04:42 PM
Cho Dennis	See Remarks	Feb 11 '26	Sale	49.93	5,000	249,650	138,581	Feb 13 04:05 PM
CHESS ROBERT	Director	Feb 13 '26	Proposed Sale	48.26	2,184	105,401		Feb 13 03:17 PM
Finn Patrick John	Officer	Feb 12 '26	Proposed Sale	50.23	3,500	175,789		Feb 12 05:00 PM
Laponis Adam	Officer	Feb 12 '26	Proposed Sale	50.00	7,000	350,000		Feb 12 01:07 PM
Cho Dennis	Officer	Feb 11 '26	Proposed Sale	49.93	5,000	249,650		Feb 11 12:03 PM
JOHANNESSEN JAN	Director	Feb 06 '26	Sale	47.91	2,200	105,395	17,754	Feb 09 04:26 PM
JOHANNESSEN JAN	Director	Feb 06 '26	Proposed Sale	47.91	2,200	105,395		Feb 06 03:16 PM
Finn Patrick John	President and COO	Feb 03 '26	Sale	46.58	2,705	125,988	307,788	Feb 05 04:05 PM
Cho Dennis	See Remarks	Feb 03 '26	Sale	46.58	1,099	51,187	143,581	Feb 05 04:05 PM
Leproust Emily M.	Chief Executive Officer	Feb 03 '26	Sale	46.58	5,001	232,927	869,312	Feb 05 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Feb 04 '26	Sale	45.65	7,000	319,536	58,738	Feb 05 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Feb 03 '26	Sale	46.58	175	8,151	65,738	Feb 05 04:05 PM
Green Paula	SVP of Human Resources	Feb 03 '26	Sale	46.58	1,194	55,612	165,445	Feb 05 04:05 PM
WERNER ROBERT F.	Officer	Feb 04 '26	Proposed Sale	45.65	7,000	319,533		Feb 04 02:29 PM
Finn Patrick John	Officer	Feb 03 '26	Proposed Sale	46.58	2,705	125,987		Feb 03 03:44 PM
WERNER ROBERT F.	Officer	Feb 03 '26	Proposed Sale	46.58	175	8,151		Feb 03 03:26 PM
Green Paula	Officer	Feb 03 '26	Proposed Sale	46.58	1,194	55,611		Feb 03 03:23 PM
Cho Dennis	Officer	Feb 03 '26	Proposed Sale	46.58	1,099	51,186		Feb 03 03:20 PM
Leproust Emily M.	Officer	Feb 03 '26	Proposed Sale	46.58	5,001	232,924		Feb 03 03:19 PM
Finn Patrick John	President and COO	Jan 23 '26	Sale	44.91	2,390	107,330	310,493	Jan 27 04:05 PM
Finn Patrick John	Officer	Jan 23 '26	Proposed Sale	44.91	2,390	107,329		Jan 23 03:17 PM
Laponis Adam	Chief Financial Officer	Jan 13 '26	Sale	40.00	3,000	120,000	137,031	Jan 15 04:13 PM
Finn Patrick John	President and COO	Jan 13 '26	Option Exercise	8.82	3,279	28,921	336,162	Jan 15 04:13 PM
Finn Patrick John	President and COO	Jan 13 '26	Sale	40.00	23,279	931,160	312,883	Jan 15 04:13 PM
Laponis Adam	Chief Financial Officer	Jan 09 '26	Sale	35.26	2,738	96,545	140,031	Jan 13 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TWST

Twist Bioscience Corp

Upgrade your Finviz experience